Ori Hassin

986 total citations · 1 hit paper
8 papers, 522 citations indexed

About

Ori Hassin is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ori Hassin has authored 8 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Oncology. Recurrent topics in Ori Hassin's work include Hippo pathway signaling and YAP/TAZ (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Bacillus and Francisella bacterial research (1 paper). Ori Hassin is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Bacillus and Francisella bacterial research (1 paper). Ori Hassin collaborates with scholars based in Israel, Germany and Netherlands. Ori Hassin's co-authors include Moshe Oren, Ravid Straussman, Ron Rotkopf, Saptaparna Mukherjee, Michal Lotem, Sharathchandra Arandkar, Raya Eilam, Giuseppe Mallel, Nishanth Belugali Nataraj and Michal Shreberk‐Shaked and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Reviews Drug Discovery.

In The Last Decade

Ori Hassin

8 papers receiving 518 citations

Hit Papers

Drugging p53 in cancer: one protein, many targets 2022 2026 2023 2024 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ori Hassin Israel 6 307 264 136 75 65 8 522
Tze‐Sian Chan Taiwan 11 377 1.2× 276 1.0× 171 1.3× 91 1.2× 83 1.3× 22 627
Carla Azzurra Amoreo Italy 15 249 0.8× 193 0.7× 148 1.1× 75 1.0× 45 0.7× 25 492
Youcheng Zhang China 6 296 1.0× 338 1.3× 221 1.6× 42 0.6× 45 0.7× 14 578
He Dou China 5 302 1.0× 218 0.8× 207 1.5× 99 1.3× 126 1.9× 10 646
Kevin S. Quackenbush United States 12 228 0.7× 219 0.8× 112 0.8× 71 0.9× 30 0.5× 17 423
Gabriela Koifman Israel 11 342 1.1× 261 1.0× 150 1.1× 34 0.5× 37 0.6× 12 486
Xueqing Yao China 13 360 1.2× 210 0.8× 230 1.7× 103 1.4× 118 1.8× 51 635
Antonio Lucena-Cacace Spain 14 365 1.2× 261 1.0× 104 0.8× 40 0.5× 47 0.7× 23 598
Diego Serrano Spain 15 410 1.3× 278 1.1× 159 1.2× 136 1.8× 138 2.1× 25 750
Jin‐Qiu Chen United States 10 313 1.0× 282 1.1× 86 0.6× 40 0.5× 131 2.0× 17 602

Countries citing papers authored by Ori Hassin

Since Specialization
Citations

This map shows the geographic impact of Ori Hassin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ori Hassin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ori Hassin more than expected).

Fields of papers citing papers by Ori Hassin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ori Hassin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ori Hassin. The network helps show where Ori Hassin may publish in the future.

Co-authorship network of co-authors of Ori Hassin

This figure shows the co-authorship network connecting the top 25 collaborators of Ori Hassin. A scholar is included among the top collaborators of Ori Hassin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ori Hassin. Ori Hassin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hassin, Ori, Felix C. E. Vogel, Max D. Wellenstein, et al.. (2023). p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells. Proceedings of the National Academy of Sciences. 120(52). e2311460120–e2311460120. 6 indexed citations
2.
Gershoni, Anat, Ori Hassin, Nishanth Belugali Nataraj, et al.. (2023). TAZ facilitates breast tumor growth by promoting an immune‐suppressive tumor microenvironment. Molecular Oncology. 17(12). 2675–2693. 6 indexed citations
3.
Aylon, Yael, Noa Furth, Giuseppe Mallel, et al.. (2022). Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature Communications. 13(1). 7199–7199. 5 indexed citations
4.
Hassin, Ori & Moshe Oren. (2022). Drugging p53 in cancer: one protein, many targets. Nature Reviews Drug Discovery. 22(2). 127–144. 410 indexed citations breakdown →
5.
Mallel, Giuseppe, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked, et al.. (2021). TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proceedings of the National Academy of Sciences. 118(23). 72 indexed citations
6.
Hassin, Ori, et al.. (2021). Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy. Journal of Clinical Medicine. 10(4). 592–592. 4 indexed citations
7.
Hassin, Ori, et al.. (2020). Listeria Meningitis in an Immunocompetent Adolescent.. PubMed. 22(3). 195–196. 2 indexed citations
8.
Shitrit, Ariella Bar‐Gil, Yaël Cohen, Ori Hassin, et al.. (2018). Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our ‘IBD MOM’ Clinic. Digestive Diseases and Sciences. 63(7). 1774–1781. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026